Transplantation proceedings

publication venue for

Resolution of Disseminated Angiosarcoma in a Kidney Transplant Recipient After Treatment With Sirolimus: A Case Report. 2022
A Kidney Transplant Recipient With Coronavirus Disease 2019: Utility of a Prognostication Score. 2020
Pegylated Bovine Carboxyhemoglobin (SANGUINATE) in a Jehovah's Witness Undergoing Liver Transplant: A Case Report. 2018
Pancreas Transplantation Is Feasible in Donors With Shprintzen-Goldberg Syndrome. 2017
Treatment of Refractory Gastrointestinal Bleeding in Patients With Portal Hypertension: A Case Series and Treatment Algorithm. 2017
Liver transplantation in an adult with adenomatosis and congenital absence of the portal vein: a case report. 2014
Pulmonary embolus originating from renal vein stump thrombus after laparoscopic living donor nephrectomy: case report. 2014
Kidney transplantation immediately following excision of a malignant tumor from the donor kidney: a case report with long-term follow-up. 1982
Absence of demonstrable suppressor cell activity in a severe combined immunodeficiency patient with a sustained engraftment of DR-positive maternal T cells. 1981
Reconstitution of immunologic function in a patient with severe combined immunodeficiency following transplantation of marrow from an HLA-A,B,C nonidentical but MLC-compatible paternal donor. 1979
Successful transplantation of marrow from an HLA-A, -B, -D mismatched heterozygous sibling donor into an HLA-D-homozygous patient with aplastic anemia. 1978
Analysis of Immune Cell Repopulation After Anti-thymocyte Globulin Administration for Steroid-Resistant T-cell-mediated Rejection.. 52. 2020
The Pancreas Can Take the Cold: Lower Waitlist Times Through Importation.. 49. 2017
Cardiac Donor Risk Factors Predictive of Short-Term Heart Transplant Recipient Mortality: An Analysis of the United Network for Organ Sharing Database.. 47. 2015
Optimizing outcome of recurrent hepatitis C virus genotype 4 after living donor liver transplantation: moving forward by looking back.. 46. 2014
Outcomes of living donor renal transplants with a negative cross-match and pretransplant donor-specific antibody.. 45. 2013
Radical cystectomy and orthotopic urinary reconstruction in patients with bladder cancer after renal transplantation: clinical outcomes and description of technique.. 45. 2013
Significance of cytomegalovirus prophylaxis strategies and development of cancer in kidney transplant recipients.. 43. 2011
Cardiovascular risk assessment among potential kidney transplant candidates and perioperative outcome: analysis of 75 consecutive Middle Eastern patients.. 43. 2011
Evaluation of blood glucose levels after hepatitis B immune globulin administration utilizing two different blood glucose monitoring systems.. 42. 2010
Simultaneous kidney-pancreas transplantation for end-stage renal disease patients with insulin-dependent diabetes and detectable C-peptide.. 42. 2010
Steroid avoidance in two-haplotype-matched living donor renal transplants with basiliximab induction therapy.. 42. 2010
Physical chemical approach versus traditional technique in analyzing blood gases and electrolytes during liver transplant surgery.. 42. 2010
Imaging of human islet vascularization using a dorsal window model.. 42. 2010
Preservation of recipient middle hepatic vein for drainage of anterior sector veins in adult-to-adult living-donor liver transplantation.. 41. 2009
2007: the year of regulatory change.. 41. 2009
Prisoners as organ donors: is it worth the effort? Is it ethical?. 41. 2009
Deceased donor kidney transplantation in elderly patients: is there a difference in outcomes?. 40. 2008
Open abdomen management with human acellular dermal matrix in liver transplant recipients.. 40. 2008
The market of human organs: a window into a poorly understood global business.. 40. 2008
Antiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B.. 39. 2007
Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.. 39. 2007
Changes in abdominal wounds following treatment with sirolimus and steroids in a rat model.. 38. 2006
Examination of gene expression profile of functional human pancreatic islets after 2-week culture.. 38. 2006
Microscopic intrarenal particles after pulsatile machine preservation do not adversely affect outcomes after renal transplantation.. 38. 2006
Serial peripheral blood cytotoxic lymphocyte gene expression measurements for prediction of pancreas transplant rejection.. 38. 2006
Difficult vascular access in patients with end-stage renal failure.. 38. 2006
Split liver transplantation.. 38. 2006
Liver transplantation for hepatitis B in the United States.. 37. 2005
A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.. 37. 2005
Assessment of human islet viability using various mouse models.. 37. 2005
OP-142 gene expression profile of nonfunctional human pancreatic islets: predictors of transplant failure?. 37. 2005
Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.. 37. 2005
Identification of early tolerance regulator genes induced by allochimeric therapy using microarray-based genomewide scan.. 37. 2005
Are autoimmune diseases or glomerulonephritis affecting the development of panel-reactive antibodies in candidates for renal transplantation?. 37. 2005
Examination of the molecular signature associated with islet dysfunction.. 37. 2005
Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.. 37. 2005
Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients?. 37. 2005
Transplantation of single pediatric kidneys into adult recipients.. 37. 2005
Allochimeric therapy induces unique regulatory T cells that mitigate chronic rejection.. 37. 2005
The impact of total plasma exchange on early allograft dysfunction.. 36. 2004
Pushing the envelope in renal preservation; improved results with novel perfusate modifications for pulsatile machine perfusion of cadaver kidneys.. 36. 2004
Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.. 36. 2004
Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients.. 36. 2004
Renal pathology and clinical presentations of polyomavirus nephropathy in simultaneous kidney pancreas transplant recipients compared with kidney transplant recipients.. 36. 2004
The effect of pancreas transplantation on peripheral vascular disease complications.. 36. 2004
A liver transplant center experience with liver dialysis in the management of patients with fulminant hepatic failure: a preliminary report.. 36. 2004
New aspects of posttransplant nephrotic syndrome: clinicopathologic correlations with outcomes.. 36. 2004
Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice.. 35. 2003
Biliary complications after adult living donor liver transplantation.. 35. 2003
Conversion to sirolimus in solid organ transplantation: a single-center experience.. 35. 2003
Evaluation of the potential living donor.. 35. 2003
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients.. 35. 2003
Ten years of sirolimus therapy for human renal transplantation: the University of Texas at Houston experience.. 35. 2003
Relationship between posttraumatic stress disorder and emotional conditions in families of the cadaveric donor population.. 35. 2003
Emotional conditions of donor families: a comparison of Japanese and American outcomes.. 34. 2002
Posttraumatic stress disorder in the families of cadaveric and living donor population: a comparison of Japanese and American outcomes.. 34. 2002
Improving results in solitary pancreas transplantation with portal-enteric drainage and thymoglobulin induction.. 34. 2002
Regulatory T cells induced by allochimeric major histocompatability class I therapy inhibit allograft apoptosis.. 34. 2002
Allochimeric class I MHC inhibits chronic rejection in cardiac allografts.. 33. 2001
Amelioration of hepatic ischemia/reperfusion injury with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.. 33. 2001
An oral formulation for intracellular adhesion molecules-1 antisense oligonucleotides.. 33. 2001
Angiotensin II receptor blockade: a novel strategy to prevent immunosuppressant-associated cancer progression.. 33. 2001
Death of alloreactive T cells sets the stage for immunoregulation to act.. 33. 2001
Development of an oral formulation for ICAM-1 antisense oligonucleotides.. 33. 2001
Factors determining outcome of liver transplantation for hepatocellular carcinoma associated with hepatitis C cirrhosis.. 33. 2001
Induction of long-term islet allograft survival in two rat strains by a single allochimeric class I MHC molecule.. 33. 2001
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation.. 33. 2001
Long-term outcomes in simultaneous kidney-pancreas transplant recipients with portal-enteric versus systemic-bladder drainage.. 33. 2001
MHC-independent allograft vascular disease: mRNA profile in the MHC congenic rat heterotopic cardiac transplant model.. 33. 2001
Methoxyethyl modification of phosphorothioate ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.. 33. 2001
Nine-year experience with 126 pancreas transplants with portal-enteric drainage.. 33. 2001
Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study.. 33. 2001
Phosphorothioate/methoxyethyl-modified ICAM-1 antisense oligonucleotides improves prevention of ischemic/reperfusion injury.. 33. 2001
Posttransplant lymphoproliferative disorders: single center experience.. 33. 2001
Psychiatric complications after liver transplantation.. 33. 2001
Renal allograft surveillance by mRNA profiling of urinary cells.. 33. 2001
Role of surveillance biopsies in monitoring recipients of pancreas alone transplants.. 33. 2001
Simultaneous kidney-pancreas transplant with systemic-enteric versus portal-enteric drainage.. 33. 2001
Ten years of chronic immunosuppressive therapy following orthotopic liver transplantation: impact on health and quality of life.. 33. 2001
Immunologic monitoring: implications for treatment of rejection.. 32. 2000
T-cell antigen recognition and costimulatory pathways: implications for the induction of transplantation tolerance.. 32. 2000
Improved outcome after intestinal transplantation: an 8-year, single-center experience.. 32. 2000
Supplemental reduced glutathione during cold ischemia does not improve early renal allograft function.. 32. 2000
Is common femoral artery flow affected by the ipsilateral transplanted kidney?. 31. 1999
Blockade of CD40L/CD40 costimulatory pathway in a DST presensitization model of islet allograft leads to a state of Allo-Ag specific tolerance and permits subsequent engraftment of donor strain islet or heart allografts.. 31. 1999
Excision and immediate revascularization for hepatic artery pseudoaneurysm following liver transplantation.. 31. 1999
Heart rate variability and quality of life following kidney and pancreas-kidney transplantation.. 31. 1999
Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients.. 31. 1999
Potential use of marginal donors for pancreas transplantation.. 31. 1999
Rejection of hamster cardiac xenografts by rat CD4+ or CD8+ T cells.. 31. 1999
Surgical complications after pancreas transplantation with portal-enteric drainage.. 31. 1999
Transplanted hepatocytes infected with a complement receptor type 1 (CR1)-containing recombinant adenovirus are resistant to hyperacute rejection.. 31. 1999
Use of gene therapy for tolerogenic signals.. 31. 1999
Prolonged patency of hamster aortic xenografts in rat by cryopreservation.. 30. 1998
Synchronous intestinal transplantation inhibits post resection adaptation.. 30. 1998
Conversion to tacrolimus to ameliorate cyclosporine toxicity in kidney recipients.. 30. 1998
Impact of kidney-pancreas transplantation on the progression of peripheral vascular disease in diabetic patients with end-stage renal disease.. 30. 1998
Molecular correlates of human renal allograft rejection.. 30. 1998
Quantitative competitive polymerase chain reaction: design and synthesis of mRNA-specific competitor DNA templates and their clinical usage.. 30. 1998
Effect of cyclosporine on chronic graft vascular disease in a rat cardiac isograft model.. 30. 1998
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.. 30. 1998
Stabilization of bone mass after renal transplant with preemptive care.. 30. 1998
Superior efficacy of oral ganciclovir over oral acyclovir for cytomegalovirus prophylaxis in kidney-pancreas and pancreas alone recipients.. 30. 1998
Changes in bone mineral density after renal transplantation.. 30. 1998
Effects of renal transplantation on body composition.. 30. 1998
Tumor necrosis factor-alpha is persistently expressed in cardiac allografts in the absence of histological or clinical evidence of rejection.. 30. 1998
Influence of human donor factors on pancreatic collagenase digestion.. 30. 1998
Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.. 30. 1998
No correlation between in vitro and in vivo function of human islets.. 30. 1998
Pancreas transplant graft evaluation using the MIBI scan--a useful tool.. 30. 1998
Solitary pancreas transplantation using the portal-enteric technique.. 30. 1998
Studies of the impact of pancreas-kidney and kidney transplantation on peripheral nerve conduction in diabetic patients.. 30. 1998
Sustained improvement in cardiac function 24 months following pancreas-kidney transplant.. 30. 1998
Kidney transplantation utilizing donors from both age extremes.. 29. 1997
Should pediatric donors younger than 2 years of age be used in kidney transplantation?. 29. 1997
Localization of tolerogenic epitopes in the alpha 1 helical region of the rat class I major histocompatibility complex molecule.. 29. 1997
A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints Conference.. 29. 1997
Clinical implications of flow cytometry B cell crossmatching in renal transplantation.. 29. 1997
Construction, function and in vivo expression of a complement receptor type 1 containing recombinant adenovirus for use in xenotransplantation.. 29. 1997
Detection of recurrent hepatitis B after OLT in patients treated with HBIG prophylaxis using graft-biopsy staining, anti-HBs titers and hepatitis B serology.. 29. 1997
Evidence for V beta restricted recognition of HLA-DR alleles.. 29. 1997
Improved outcome of patients with portal-enteric pancreas transplantation.. 29. 1997
In vivo hyperexpression of transforming growth factor-beta 1 in humans: stimulation by cyclosporine.. 29. 1997
Incidence of kidney and pancreas rejection following portal-enteric versus systemic-bladder pancreas-kidney transplantation.. 29. 1997
Intrarenal display of cytotoxic attack molecules during rejection.. 29. 1997
Renal histology with varying FK506 blood levels.. 29. 1997
A novel series of low molecular weight immunosuppressive agents.. 28. 1996
Enteric neuropeptide abnormalities following small bowel resection and the effect of a tapering and lengthening procedure.. 28. 1996
Response of the terminal ileum to intestinal resection and bypass.. 28. 1996
Impact of early acute rejection on outcome of HLA-mismatched living related donor kidney transplants.. 28. 1996
Long-term beneficial effects of a nifedipine-supplemented immunosuppressive regimen in kidney transplantation.. 28. 1996
Racial differences in long-term renal allograft outcome.. 28. 1996
Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.. 28. 1996
Deletion analysis of the porcine E-selectin promoter.. 28. 1996
Expanding the donor pool with the use of en bloc pediatric kidneys in adult recipients.. 28. 1996
The use of immunocytochemistry (LCA and LEU-7) in diagnosis of renal allograft rejection.. 28. 1996
Identification of quality-of-life outcomes distinguishing diabetic kidney-alone and pancreas-kidney recipients.. 27. 1995
Stability of bladder function two years following simultaneous pancreas-kidney transplantation.. 27. 1995
Use of amphotericin B to clear fungal contamination of islet tissue isolated from contaminated source pancreas.. 27. 1995
Use of glucose disappearance rates to monitor beta-cell function of pancreas allografts.. 27. 1995
Altered expression of cytokine genes by CD45RB monoclonal antibody in renal allograft rejection.. 27. 1995
Changes in cardiac function of type I diabetics following pancreas-kidney and kidney-alone transplantation.. 27. 1995
Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.. 27. 1995
Induction of transplantation tolerance by perioperative injection of "quasi-self" chimeric class I MHC antigen combined with a short cyclosporine course.. 27. 1995
One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events.. 27. 1995
Patterns of expression of endothelial leukocyte adhesion molecules upon revascularization of transplanted kidneys in correlation with allograft pathology.. 27. 1995
Restricted V beta usage by alloreactive T cells responding to specific HLA-DR alleles.. 27. 1995
The diagnostic accuracy of urine cytological analysis in the rapid assessment of acute renal allograft dysfunction.. 27. 1995
Class I major histocompatibility complex antigen disparity is not a barrier to successful pancreatic islet cell engraftment.. 26. 1994
Consistent long-term allograft survival in murine pancreatic islet transplants without immunosuppression.. 26. 1994
Cyclosporine levels during pregnancy.. 26. 1994
Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.. 26. 1994
Involvement of tumor necrosis factor in development of anti-CD3 monoclonal antibody induced pulmonary edema.. 26. 1994
Basic considerations for the procurement of intestinal grafts.. 26. 1994
Candidates for intestinal transplantation and possible indicators of outcome.. 26. 1994
Clustered motor activity--the dominant motor pattern in short bowel syndrome: an analysis of regional and temporal distribution.. 26. 1994
Early infectious complications of liver-intestinal transplantation in children: preliminary analysis.. 26. 1994
Eating difficulties in the pediatric small bowel recipient: the role of the nutritional management team.. 26. 1994
Effect of intestinal harvesting and perfusion on serum and tissue diamine oxidase levels.. 26. 1994
Evolution of surgical techniques in clinical intestinal transplantation.. 26. 1994
FK 506 in small bowel transplant recipients: pharmacokinetics and dosing.. 26. 1994
Intestinal muscle response to intestinal resection and restorative procedures.. 26. 1994
Intestinal transplantation and bacterial overgrowth in humans.. 26. 1994
Intestinal transplantation at the University of Pittsburgh.. 26. 1994
Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients.. 26. 1994
Lipopolysaccharide alters intestinal epithelial cell gene expression of regulatory cytokines and intercellular adhesion molecules.. 26. 1994
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression.. 26. 1994
Rejection of human intestinal allografts: alone or in combination with the liver.. 26. 1994
Role of macrophages in intestinal epithelial cell-induced immune responses.. 26. 1994
Use of the D-xylose absorption test in monitoring intestinal allografts.. 26. 1994
Expression of the regenerating gene in the pancreas of aging mice.. 26. 1994
Glucose disappearance constant (KG) provides an alternative diagnostic marker of acute pancreas allograft rejection.. 26. 1994
Improved autonomic and gastric function in pancreas-kidney vs kidney-alone transplantation contributes to quality of life.. 26. 1994
Improvement in quality of life reported by diabetic recipients of kidney-only and pancreas-kidney allografts.. 26. 1994
Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney-pancreas transplantation.. 26. 1994
Role of 15-deoxyspergualin in the prevention of diabetes in the BB/w rat.. 26. 1994
Pediatric renal transplant experience in Memphis, Tennessee.. 26. 1994
Randomized trial of ganciclovir followed by high-dose oral acyclovir vs ganciclovir alone in the prevention of cytomegalovirus disease in pediatric liver transplant recipients: preliminary analysis.. 26. 1994
Frequent achievement of a drug-free state after orthotopic liver transplantation.. 25. 1993
Donor-soluble histocompatibility antigen selectively potentiates suppressor elements while decreasing the frequency of alloantigen-specific T cytotoxic cells.. 25. 1993
Clinical intestinal transplantation.. 25. 1993
Transmembrane signaling requirements of T cells.. 25. 1993
Anti-CD2 monoclonal antibodies synergize with anti-CD3 to prolong allograft survival and decrease cytokine production.. 25. 1993
Comparative analysis of concurrent urine cytology and kidney aspirate in the rapid assessment of acute allograft dysfunction.. 25. 1993
Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant.. 25. 1993
Effect of repetitive doses of soluble human complement receptor type 1 on survival of discordant cardiac xenografts.. 25. 1993
Elevated tumor necrosis factor levels are predictive for pancreas allograft transplant rejection.. 25. 1993
Improvement in autonomic function following pancreas-kidney versus kidney-alone transplantation.. 25. 1993
Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.. 25. 1993
Nutritional management of intestinal transplant recipients.. 25. 1993
Pancreas transplantation with portal venous and enteric drainage eliminates hyperinsulinemia and reduces postoperative complications.. 25. 1993
Results of a prospective, randomized double-blind study comparing standard vs low-dose OKT3 induction therapy.. 25. 1993
Retrospective analysis of the role of pancreatic biopsy (open and transcystoscopic technique) in the management of solitary pancreas transplants.. 25. 1993
Two-signal model for T-cell activation: molecular mechanisms.. 25. 1993
Two-year experience with FK 506 in pediatric patients.. 25. 1993
T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.. 24. 1992
A new method to harvest multiple organs from non-heart-beating donors by use of a percutaneous cardiopulmonary support machine.. 24. 1992
Alloantigen-presenting activity of cells from rat small intestine.. 24. 1992
Host immunosuppression after combined liver/intestine transplantation in the rat.. 24. 1992
Infectious complications after human small bowel transplantation.. 24. 1992
Lipoprotein level improvements with pancreas-kidney transplantation.. 24. 1992
Pancreas transplantation with portal venous drainage and enteric exocrine diversion: a new technique.. 24. 1992
Rat intestinal epithelial cells as accessory cells in alloimmune responses.. 24. 1992
The long-term function of canine jejunoileal autotransplants--insights into allograft physiology.. 24. 1992
15-day survival in pig-to-baboon heterotopic cardiac xenotransplantation.. 24. 1992
A comparison of mice and rats as recipients for canine islet xenografts.. 24. 1992
Prolongation of guinea pig cardiac xenograft survival in rats by soluble human complement receptor type 1.. 24. 1992
TLI induces specific B-cell unresponsiveness and long-term monkey heart xenograft survival in cyclosporine-treated baboons.. 24. 1992
Clinical small bowel or small bowel plus liver transplantation under FK 506.. 23. 1991
Effect of FK 506 and cyclosporine on plasma cholesterol levels in rabbits.. 23. 1991
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation.. 23. 1991
Infectious complications of pediatric liver transplantation under FK 506.. 23. 1991
Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.. 23. 1991
Neopterin, amyloid A, C-reactive protein, gamma-interferon, and interleukin-2 receptor in diagnosis of posttransplantation rejection.. 23. 1991
Cross-species mixed chimerism (mouse + rat----mouse): facilitated engraftment of rat stem cells with untreated rat bone marrow.. 23. 1991
Detection of transplant arteriopathy: does exercise thallium scintigraphy improve noninvasive diagnostic capabilities?. 23. 1991
Effects of intracoronary acetylcholine infusion early versus late after heart transplant.. 23. 1991
IL-2 activated killer cell activity is associated with the early phase of allograft rejection.. 23. 1991
Improvement in autonomic function following combined pancreas-kidney transplantation.. 23. 1991
Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.. 23. 1991
One-year survival of heterotopic heart primate xenografts treated with total lymphoid irradiation and cyclosporine.. 23. 1991
Signaling normal human T-cells: synergism between CD2 antigen and CD3/T cell receptor alpha beta complex in the elicitation of IL-2 and IL-2 receptor gene expression.. 23. 1991
Searches for matched and closely matched marrow donors undertaken in a paediatric unit.. 22. 1990
An assessment of the impact of required request legislation on the availability of cadaveric organs for transplantation.. 22. 1990
Renal transplant blood flow on TcDPTA scan predicts recovery from delayed graft function.. 22. 1990
Survey of attitudes of health care professionals toward organ donation.. 22. 1990
The effect of donor source on the outcome of living related renal transplantation.. 22. 1990
Analysis of spontaneous blastogenesis profiles in recipients of renal allografts.. 21. 1989
Does depletion of donor dendritic cells in an organ allograft lead to prolongation of graft survival on transplantation?. 21. 1989
Identification of the nature of hemostatic failure during transplantation of the liver.. 21. 1989
Prevention of pulmonary edema in autoperfusing heart-lung preparation by FUT-175 and leukocyte depletion.. 21. 1989
Resuscitation and preservation of agonally arrested hearts for transplantation: a study of 24 hour stored canine hearts.. 21. 1989
Signaling via the T-cell antigen receptor heterodimer and the CD2 antigen: a novel, synergistic pathway for activation of T-cells.. 21. 1989
The mechanism of discordant xenograft rejection.. 21. 1989
The role of natural suppression in mediating resistance to antibody-facilitated bone marrow engraftment.. 21. 1989
Failure to induce chimerism or tolerance in mice with monoclonal anti-T cell antibodies plus allogeneic bone marrow infusion.. 20. 1988
Improved results of preservation of hepatic grafts preflushed with albumin and prostaglandins.. 20. 1988
Intermediate normothermic hemoperfusion of rat kidneys: functional aspects and a study into the effect of free radical scavengers.. 20. 1988
Procurement of both liver and whole pancreas/duodenum allografts from a single donor without the use of interposition vascular grafts on transplantation.. 20. 1988
Effects of in vivo administration of human recombinant IL-2 to cynomolgus monkeys after autologous bone marrow transplantation.. 19. 1987
Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.. 19. 1987
Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristics.. 19. 1987
HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.. 19. 1987
In vitro correlates of graft-host tolerance after HLA-matched and mismatched marrow transplants: suggestions from limiting dilution analysis.. 19. 1987
The diagnostic, prophylactic, and therapeutic uses of monoclonal antibodies to human cytomegalovirus.. 19. 1987
Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin).. 19. 1987
Allotransplantation of cultured retinal epithelium to Bruch's membrane in the rabbit eye.. 19. 1987
An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping.. 19. 1987
Cell cycle analysis of activated mononuclear blood cells of renal allograft recipients.. 19. 1987
Current developments in marrow transplantation.. 19. 1987
Human T cell activation: participation of Tll antigen (CD2, T,gp.50) in T cell-accessory cell interactions.. 19. 1987
Increased incidence of immediate function after cadaveric kidney transplantation resulting from lidocaine pretreatment of the donor.. 19. 1987
Intermediate normothermic hemoperfusion doubles safe cold preservation of rat kidneys.. 19. 1987
Optimization of donor specific blood transfusion in kidney transplantation.. 19. 1987
Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors.. 19. 1987
T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation.. 19. 1987
The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine.. 19. 1987
Detection of alloimmune memory cells by chemical modification of the cell surface with mitogenic oxidizing agents.. 13. 1981
Alloantigen-independent activation of alloimmune memory cells by soluble factors from mitogen-primed cells.. 13. 1981
Focal segmental glomerulosclerosis in kidney transplants.. 13. 1981
Papovavirus excretion following marrow transplantation: incidence and association with hepatic dysfunction.. 13. 1981
Total lymphoid irradiation (TLI) and allogeneic marrow transplantation for enzyme replacement therapy and immunotherapy of leukemia in mice.. 13. 1981
Immunosuppression and tolerance after total lymphoid irradiation (TLI).. 12. 1980
Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.. 12. 1980
Association of HLA in immune response to influenza-A immunization.. 11. 1979
Generation of specific secondary cytotoxic T cells by treatment of long-term primary MLC cells with sodium periodate.. 11. 1979
The effect of donor pretreatment and low-dose immunosuppression on the 24-hour preserved canine renal allograft.. 11. 1979
Adverse presensitization: detection by utilization of B lymphoblastoid cell panels.. 11. 1979
Immunosuppressive properties of placental-source gamma globulin: results of a 5-year clinical investigative study in a cadaver kidney transplant program.. 11. 1979
Transplantation tolerance after total lymphoid irradiation.. 11. 1979
Use of HLA genotypically different donors in bone marrow transplantation.. 11. 1979
HLA-D activity in lymphocyte subcellular fractions.. 10. 1978
Regulation of human mixed lymphocyte culture reactions: augmentation of proliferation and generation of cytotoxic cells.. 10. 1978
Response to wheat antigen in in vitro lymphocyte transformation among HLA-B8-positive normal donors.. 10. 1978
Anti-Ia antibody eluted from rejected human renal allografts.. 10. 1978
Detection of anti-donor "Ia" antibodies: a strong correlate of rejection.. 10. 1978
Posttransplant immunologic monitoring of the renal allograft recipient.. 10. 1978
Accelerated graft loss: association with presensitization to donor B-cell (Ia) antigens.. 10. 1978
Intragraft immune events causing vascularized organ graft rejection.. 10. 1978
Evidence for close association between B-cell Fc receptors and Ia antigens, and independence from HLA-A,B locus-determined antigens.. 9. 1977
Immunologic monitoring in the diagnosis of renal allograft rejection.. 9. 1977
Presensitization to donor B-cell ("Ia") antigens is associated with early allograft failures.. 9. 1977
Biologic immunosuppression in renal transplantation using retroplacental (maternal) source gamma globulin.. 9. 1977
Use of total lymphoid irradiation in tissue transplantation in mice.. 9. 1977
Hematologic analysis of clinical bone marrow grafting evaluated by in vitro cultures.. 8. 1976
Immunogenetic identification of functional T-cell subsets.. 8. 1976
Retroplacental serum factors and passive enhancement.. 8. 1976
Physicochemical characteristics of several mediators from stimulated guinea pig and human lymphocytes.. 4. 1972
Induction of tolerance to antilymphocyte globulin in man.. 3. 1971
Antilymphocyte induction: effective immune suppression when the stakes are high? 2010
Articles published in Transplant Proceedings (Guarrera et al 36(5):1257- 60, Polyak et al 32(1):32-4, Polyak et al 31(5):2091-3, Polyak et al 29(8):3582-3). 2005
Report of the Third Banff Conference on Allograft Pathology (July 20-24, 1995) on classification and lesion scoring in renal allograft pathology. 1996
Diabetes mellitus and renal transplantation in adults: is there enough evidence for diagnosis, treatment, and prevention of new-onset diabetes after renal transplantation? 2014
Impact of human leukocyte antigen molecules E, F, and G on the outcome of transplantation. 2014
Concomitance of IgA nephropathy and diabetic nephropathy in a kidney allograft: case report and review of the literature. 2014
A review of the evidence for use of thymoglobulin induction in renal transplantation. 2010
Borderline changes in the Banff schema: rejection or no rejection? 2004
A review of the safety of generic drugs. 1999
The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design. 1999
Positive and negative signaling pathways. 1999
T-cell growth factors in allograft rejection and tolerance. 1999
Immunoregulatory and fibrogenic activities of cyclosporine: a unifying hypothesis based on transforming growth factor-beta expression. 1996
Adhesion molecules as markers of acute cellular rejection of renal allografts. 1996
Transmembrane signaling requirements of T cells: implications for regulation of alloimmunity. 1995
Xenotransplantation: endothelial cell activation and beyond. 1995
Current concepts of leukemia and results of recent treatment programs. 1978
Severe combined immunodeficiency: transplantation approaches for patients lacking an HLA genotypically identical sibling. 1978
Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection. 1977
Relevance of major human histocompatibility determinants in clinical bone marrow transplantation. 1976

VIVO Weill Cornell Medical College

Transplantation proceedings Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)